Coronary atherosclerotic burden in non-ischemic dilated cardiomyopathies: Prognostic implications. A substudy of 3C registry - 09/01/21
, A. Jankowski 2, M. Salvat 1, C. Augier 1, C. Casset 1, M. Maurin 1, G. Vanzetto 1, 3, L. Djaileb 3, 4, L. Riou 3, D. Fagret 3, 4, C. Ghezzi 3, G. Barone-Rochette 1, 3
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Introduction |
Atherosclerosis is associated with a worse prognosis in many diseases, but its impact in non-ischemic dilated cardiomyopathy (NIDCM) is not known.
Purpose |
This study investigated the prognostic value of coronary atherosclerotic burden, as measured by Gensini score, in a cohort of NIDCM patients.
Methods |
In total, 139 patients with left ventricular (LV) dysfunction due to NIDCM were classified according to both invasive coronary angiography (ICA) and cardiovascular magnetic resonance (CMR) imaging data in 3 subtypes of NIDCM: true NIDCM, NIDCM with bystander coronary artery disease (CAD) and NIDCM with bystander myocardial infarction (MI). Percentage, extent, location of fibrosis was assessed with CMR and coronary atherosclerotic burden by calculating Gensini score. Primary endpoint was a composite of cardiovascular mortality, non-fatal MI and revascularisation by percutaneous coronary intervention (PCI).
Results |
Out of 139 patients (mean age 59.4±14.7 years old, 74% male), there were 101 patients (73%) with true NIDCM, 30 patients (22%) with NIDCM and bystander MI and 8 patients (5%) with NIDCM and bystander MI. 6 patients (4.3%) died and 6 (4.3%) underwent PCI during a median follow-up of 34.2±18 months (Table 1). Gensini score predicted primary composite endpoint, in univariate and multivariate analysis, hazard ratio=1.08, confidence interval 95% (1.034–1.13) P=0.001, as well as a history of CAD, LV ejection fraction (LVEF) and age (P<0.02, P=0.008 and P=0.024 respectively), while fibrosis did not.
Conclusion |
Coronary atherosclerotic burden, as measured by Gensini score, is a new prognostic factor in NIDCM. Assessing this parameter improves risk stratification and could be used to help personalise treatment in this population (Fig. 1).
Le texte complet de cet article est disponible en PDF.Plan
Vol 13 - N° 1
P. 49 - janvier 2021 Retour au numéro
Article précédent
- Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
- J. Fagot, E. Cariou, Y. Lavie-Badie, O. Lairez, V. Blanchard
- Determinants and prognostic significance of myocardial replacement fibrosis in patients with mitral valve prolapse
- A. Constant Dit Beaufils, O. Huttin, A. Jobbe-Duval, N. Piriou, T. Senage, C. Cueff, C. Venner, D. Mandry, J. Sellal, R. Capoulade, A. Thollet, J. Trochu, K. Warin-Fresse, P.Y. Marie, J. Schott, J. Roussel, J. Serfaty, C. Selton-Suty, T. Le Tourneau
Bienvenue sur EM-consulte, la référence des professionnels de santé.